Home Gastrointestinal Disorders

Gastrointestinal Disorders

Latest
Nexium (esomeprazole)
Gastrointestinal Disorders

Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M

Gastrointestinal Disorders

Probiotics May Not Always Benefit Gut Health

Gastrointestinal Disorders

Takeda to Co-Develop Enterome Crohn’s Disease Candidate EB8018

Malawian children [Dr. Carina King]
Gastrointestinal Disorders

Infant Diarrhea Deaths Drop Sharply in Malawi Due to Rotavirus Vaccine

Source: metamorworks/Getty Images
Gastrointestinal Disorders

Clinical Trial Will Assess Profile of Gut Microbiome in Heart Failure...

Salix Pharmaceuticals will partner with Cedars-Sinai Medical Center to discover new treatments for gastrointestinal (GI) disorders related to conditions of the gut microbiome. [Source: © Sebastian Kaulitzki/Fotolia]
Gastrointestinal Disorders

Salix, Cedars-Sinai Partner on Gut Microbiome–Related GI Treatments

Ophelia Venturelli is trying to understand the dynamic interactions of microbes that specifically reside in the human gut because of the impact they have on human health. Understanding these interactions is the first step in being able to change the microbiome in ways that benefit health. [University of Wisconsin-Madison]
Gastrointestinal Disorders

Gut Microbiome Understanding Insight Facilitated by New Platform

Bacteria have been genetically engineered to produce large amounts of tryptamine. In a mouse model of constipation
Gastrointestinal Disorders

Microbiome-Lax May Relieve Constipation

Gastrointestinal Disorders

Genentech, Microbiotica to Develop Microbiome-Based IBD Treatments

Gastrointestinal Disorders

Vivus Buys U.S., Canada Rights to Pancreaze from Janssen for $135M

Load more

Recently Featured

Stay Connected

557,160FansLike
46,470FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up